Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Does a Rapid-Onset Neck Mass Have Rheumatic Origins?

Tej Bhavsar, MD, & Nancy Joste, MD  |  Issue: September 2019  |  September 17, 2019

Persistent asymptomatic neck masses in an adult should, in general, be considered malignant until proven otherwise.

Final Thoughts

In conclusion, our case demonstrated a relatively rare presentation of amyloidosis as a localized neck mass with additional localization to the peritoneum discovered through a PET scan and confirmed by systemic elevation of monoclonal immuno­globulin fragments.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The teaching points raised in this case include the various presentations of amyloidosis, the variety of rheumatologic causes of neck masses, the nature and presentation of neck masses in general and the methods of evaluating a neck mass.


Tej Bhavsar, MD, is a recent graduate and former chief fellow of the University of New Mexico School of Medicine, Albuquerque. He is a practicing rheumatologist with the Center for Rheuma­tology based in Albany, N.Y., and sees patients in Saratoga Springs, N.Y.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Nancy Joste, MD, is director of anatomic pathology and a professor in the pathology department at the University of New Mexico School of Medicine in Albuquerque.

Acknowledgment: The authors thank Mary Barry, MD, for diagnostic assistance.

References

  1. Dhillon V, Woo P, Isenberg D. Amyloidosis in the rheumatic diseases. Ann Rheum Dis. 1989 Aug;48(8):696–701.
  2. Westermark P. Localized AL amyloidosis: A suicidal neoplasm? Ups J Med Sci. 2012 May;117(2):244–250.
  3. Knopf A, Bas M, Chaker A, et al. Rheumatic disorders affecting the head and neck: Underestimated diseases. Rheumatology (Oxford). 2011 Nov;50(11):2029–2034.
  4. Haynes J, Arnold K, Aguire-Oskins C, et al. Evaluation of neck masses in adults. Am Fam Physician. 2015 May 15;91(10):698–706.
  5. Wippold FJ II, Cornelius RS, Berger KL, et al. Expert panel on neurologic imaging. American College of Radiology ACR Appropriateness Criteria. 2012.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:AmyloidosisCancercase report

Related Articles

    What Rheumatologists Need to Know about Identifying Amyloidosis

    June 1, 2013

    Although amyloidosis is not a rheumatic disease, rheumatologists may be the first to diagnose this life-threatening condition

    The Legacy of Amyloid: Infiltration Linked to Dementia, Rheumatic Disease

    October 16, 2017

    An Unforgettable Story Her name was unforgettable. Not only did we share our given names—Simon and Simone, but her French-Canadian surname was based on this appellation, too. I was the junior resident working on our hospital’s nephrology service when she was admitted for evaluation of progressively worsening kidney disease and an overall failure to thrive….

    An Amylodosis Warning & New Drug Hope

    March 17, 2018

    SAN DIEGO—Treatments do exist that can improve the prospects of a patient with the rare disease amyloidosis, but only if clinicians keep the disease in mind and treat the patient before it’s too late, an expert said at the 2017 ACR/ARHP Annual Meeting this past November. He also discussed research that may be close to…

    Amyloidosis Is Often Underdiagnosed, Undertreated

    July 14, 2017

    CHICAGO—Caryn A. Libbey, MD, clinical associate professor of medicine at Boston University School of Medicine, described the evolving in our understanding of amyloid at the ACR’s State-of-the-Art Clinical Symposium in April. Amyloidosis is a rare disease that is often underdiagnosed and undertreated. “Even though this disease has been around for 150 years, I still consider it…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences